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Background:  Catecholamine excess along with an exaggerated sympathetic nervous system stimulation appears to play a major role in the 
pathophysiologic mechanism of Tako-tsubo cardiomyopathy (TTC). Aim of the study was to analyze the frequency of `1 and/or `2 adrenergic 
receptors which might result in susceptibility to TTC. 
Methods:  `1 and/or `2 adrenergic receptor polymorphisms in 56 patients with TTC (mean age 67.6±10.6, range 41 to 84 years, 53 female, 
94.6%) were compared with 103 normal female controls (mean age 62.4±10, range 47-92 years). Differences in genotypic frequencies between 
groups were assessed by means of the Pearson r2 test and calculation of odds ratios (O.R.) with 95% confidence intervals (CI). 
Results:  the `1 adrenoreceptor (amino acid position 389) genotype frequencies were significantly different in the two groups (homozygous Arg/
Arg 23/17, 42% vs 16%, heterozygous Arg/Gly 27/51, 49% vs 50% and homozygous Gly/Gly 5/35, 9% vs 34% in the TTC patients and controls 
respectively; O.R. 2.81, 95% CI 1.74-4.55; p<0.0001). The `2 adrenoreceptor amino acid position 16 genotype frequencies were similar in the two 
groups (homozygous Gly/Gly 6/13, 27% vs 13%, heterozygous Gly/ Arg 35/51, 63% vs 50% and homozygous Arg/Arg 15/39, 11% vs 38% in the TTC 
patients versus controls; p=0.29) while`2 adrenoreceptor amino acid position 27 genotype was significantly different (homozygous Gln/Gln 6/30, 
11% vs 29%, heterozygous Gln/Glu 31/44, 55% vs 43% and homozygous Glu/Glu 19/29, 34% vs 28% in the TTC patients and controls respectively; 
O.R. 0.61, 95% CI 0.38-0.98; p=0.029). 
Conclusions:  TTC phenotype seems to be associated with `1 adrenoreceptor amino acid position 389 and `2 adrenoreceptor amino acid 
position 27 polymorphysms.
